| P50 | author | Maria Trojanowska | Q35703497 |
| | Andreea M Bujor | Q42525588 |
| | Percival D Sampaio-Barros | Q56867885 |
| P2093 | author name string | Romy B Christmann | |
| | Paul Haines | |
| | Robert Lafyatis | |
| | Andreea M Bujor | |
| | Cristina Padilla | |
| | Monica Junie | |
| P2860 | cites work | Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea | Q24805406 |
| | Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1 | Q24811689 |
| | Adverse reactions to fluoroquinolones. an overview on mechanistic aspects | Q28199906 |
| | Ciprofloxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells | Q28574002 |
| | Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing | Q33877106 |
| | The role of Fli-1 in normal cell function and malignant transformation | Q33933215 |
| | Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin | Q35791840 |
| | The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts | Q36054245 |
| | Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy | Q37190292 |
| | Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? | Q37265882 |
| | Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma. | Q39207186 |
| | Synergistic effects of dexamethasone and quinolones on human-derived tendon cells | Q39759079 |
| | Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin | Q39918910 |
| | Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway. | Q42142681 |
| | A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. | Q42159140 |
| | Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells. | Q42483683 |
| | CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling | Q42498294 |
| | Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts | Q42525511 |
| | Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts | Q42908910 |
| | Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy | Q44213857 |
| | Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program | Q45184208 |
| | Ciprofloxacin-mediated inhibition of tenocyte migration and down-regulation of focal adhesion kinase phosphorylation | Q46114821 |
| | Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate | Q46453980 |
| | Gene expression profiles in the articular cartilage of juvenile rats receiving the quinolone antibacterial agent ofloxacin | Q46524710 |
| | Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. | Q46797117 |
| | Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts | Q46815041 |
| | Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats | Q48313289 |
| | The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension | Q48949370 |
| | Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ. | Q53872781 |
| | Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen. | Q54141807 |
| | The Effect of Ciprofloxacin on Tendon, Paratenon, and Capsular Fibroblast Metabolism | Q56658493 |
| | Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway | Q60537820 |
| | Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat | Q71035615 |
| | Decreased collagenase expression in cultured systemic sclerosis fibroblasts | Q72166912 |
| | Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts | Q73628355 |
| | Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts | Q79795007 |
| | Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta | Q81071159 |
| | Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts | Q82265444 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1473-1480 | |
| P577 | publication date | 2012-10-05 | |
| P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
| P1476 | title | Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1. | |
| P478 | volume | 30 | |